Join
Live feed
·
SECFilingvia Quantisnow
Inhibikase Therapeutics Inc. logo

SEC Form DEFA14A filed by Inhibikase Therapeutics Inc.

ByQuantisnow·Wall Street's wire, on your screen.
IKT· Inhibikase Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IKT (Inhibikase Therapeutics Inc.) and more on Quantisnow.